Literature DB >> 12079519

Immunocytochemical expression of microtubule-associated protein-2 (MAP-2) in small cell lung cancer cell lines with neuronal-like processes.

Kazuhiko Tanaka1, Takeo Terasaki.   

Abstract

Five of six human small cell lung cancer (SCLC) cell lines changed morphologically into cells with neuronal-like processes on the extracellular matrix of human lung adenocarcinoma cell line PC-9 cells (PC-9 / ECM substrate). The features of the neuronal-like processes of these SCLC cell lines were examined immunocytochemically using monoclonal antibodies against beta-chains of tubulin and microtubule-associated protein-2 (MAP-2), which is somatodendritic MAP of neurons. It was observed that beta-chains of tubulin and MAP-2 were expressed along the neuronal-like processes of SCLC cell lines. These findings suggest that the beta-chains of tubulin and MAP-2 are expressed functionally in SCLC cell lines in association with the development of dendrite-like processes on PC-9 / ECM substrate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079519      PMCID: PMC5927047          DOI: 10.1111/j.1349-7006.2002.tb01309.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

Review 1.  Current concepts in cancer: small-cell lung cancer.

Authors:  F A Greco; R K Oldham
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

Review 2.  Human cancer cell lines in Japan (author's transl).

Authors:  S Oboshi; M Sekiguchi
Journal:  Tanpakushitsu Kakusan Koso       Date:  1978-05

Review 3.  Biological, pathological and clinical features of small cell lung cancer.

Authors:  Y Shimosato; T Nakajima; S Hirohashi; S Morinaga; T Terasaki; K Yamaguchi; N Saijo; K Suemasu
Journal:  Cancer Lett       Date:  1986-12       Impact factor: 8.679

4.  Changes in cell characteristics due to culture conditions in cell lines from human small cell lung cancer.

Authors:  T Terasaki; Y Shimosato; T Nakajima; M Tsumuraya; S Morinaga; S Hirohashi; K Yamaguchi; K Kato; H Ichinose; T Nagatsu
Journal:  Jpn J Clin Oncol       Date:  1986-09       Impact factor: 3.019

5.  Distribution of phosphate-independent MAP2 epitopes revealed with monoclonal antibodies in microwave-denatured human nervous system tissues.

Authors:  J Q Trojanowski; T Schuck; M L Schmidt; V M Lee
Journal:  J Neurosci Methods       Date:  1989-08       Impact factor: 2.390

6.  Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

Authors:  A F Gazdar; D N Carney; M M Nau; J D Minna
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

7.  Small cell lung carcinoma with ectopic adrenocorticotropic hormone and antidiuretic hormone syndromes: a case report.

Authors:  H Suzuki; Y Tsutsumi; K Yamaguchi; K Abe; T Yokoyama
Journal:  Jpn J Clin Oncol       Date:  1984-03       Impact factor: 3.019

8.  The changing histopathology of lung cancer: a review of 1682 cases.

Authors:  R G Vincent; J W Pickren; W W Lane; I Bross; H Takita; L Houten; A C Gutierrez; T Rzepka
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

9.  Distribution of phosphorylated microtubule-associated protein 1B during neurite outgrowth in PC12 cells.

Authors:  H H Keating; D J Asai
Journal:  Dev Biol       Date:  1994-03       Impact factor: 3.582

10.  Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.

Authors:  D N Carney; P A Bunn; A F Gazdar; J A Pagan; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  1 in total

1.  Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment.

Authors:  Tessa Ya Sung Le Large; Btissame El Hassouni; Niccola Funel; Bart Kok; Sander R Piersma; Thang V Pham; Kenneth P Olive; Geert Kazemier; Hanneke W M van Laarhoven; Connie R Jimenez; Maarten F Bijlsma; Elisa Giovannetti
Journal:  Ther Adv Med Oncol       Date:  2019-05-10       Impact factor: 8.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.